Coeptis Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $200 | $62 | $1,863 | $0 |
Gross Profit | 155 | 17 | 931 | -431 |
EBITDA | -3,961 | -3,044 | -2,673 | -1,500 |
EBIT | -4,266 | -3,349 | -2,932 | -1,778 |
Net Income | -3,534 | -3,420 | -3,011 | -1,829 |
Net Change In Cash | 200 | 62 | 1,863 | 0 |
Free Cash Flow | -2,396 | -2,366 | -1,436 | -1,892 |
Cash | 1,996 | 4,268 | 532 | 1,137 |
Basic Shares | 3,706 | 3,073 | 1,925 | 39,807 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $75 |
Gross Profit | -1,001 | -1,001 | -1,001 | -372 |
EBITDA | -10,054 | -20,158 | -36,354 | -12,815 |
EBIT | -11,273 | -21,159 | -37,355 | -13,262 |
Net Income | -9,814 | -21,267 | -40,968 | -13,449 |
Net Change In Cash | 0 | 0 | 0 | 75 |
Free Cash Flow | -6,649 | -3,875 | -3,875 | -6,239 |
Cash | 532 | 3,791 | 3,791 | 2,179 |
Basic Shares | 1,925 | 25,690 | 14,296 | 10,915 |
